Reglan Lawsuit Filed in New Orleans

New Orleans, LAA mother in Louisiana has filed a Reglan lawsuit, claiming that her child developed tardive dyskinesia, a disorder characterized by repetitive and involuntary movements, after taking the diabetes drug.

Dawn Harris is suing Pharmaceutical Associates, Beach Products, Morton Grove Pharmaceuticals and Wockhardt in a federal court in New Orleans on behalf of her minor child, according to the Louisiana Record.

"Defendants breached these warranties (both express and implied) as the Reglan/metoclopramide was not merchantable, was unfit for its intended use and was unreasonably dangerous when comparing the benefits to the risks associated with its use," the lawsuit states.

Harris claims that she was not aware of warnings that long-term use of Reglan should be avoided and that the drug caused her child to suffer permanent, serious and disabling injuries in the form of her tardive dyskinesia.

The lawsuit seeks damages for medical expenses, mental anguish, physical pain and suffering, physical impairment, physical disfigurement, loss of earnings, loss of earning capacity, pre- and post-judgment interest and court costs.

The movements caused by tardive dyskinesia include involuntary grimacing, lip smacking and eye blinking, according to the Mayo Clinic.